Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland

Reducing the cost and risks of scaling-up biologic medicine production

20-Jun-2024 - TheCelonic Group, a Swiss Based Quality Biologics Contract Development and Manufacturing Organization (CDMO) today opened its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland. This laboratory expansion will help pharmaceutical companies develop and optimize ...

TU Graz Bundles Its Strengths in Biotechnology and Artificial Intelligence

09-May-2024 - In a multidisciplinary research project, researchers from the biosciences, process engineering and computer science want to massively increase efficiency in the development of new enzymes and process optimization. This should even enable the breakdown of forever chemicals. Graz University of ...

Global Bioenergies reaches 87% of yield target in Isobutene process

12-Oct-2018 - Global Bioenergies announces that a new milestone has been met in the development of its Isobutene process. The company announces a yield exceeding 87% of the final target during the complete production phase, at laboratory scale. The productivity is also progressing quickly. Yield and ...

Merck expands biotech capacities

Swiss facility in Aubonne grows

30-Jun-2017 - Merck inaugurated a new packaging building at its biotech manufacturing site of Aubonne, Switzerland. The inauguration ceremony was attended by Merck’s Chairman of the Executive Board and CEO Stefan Oschmann, as well as personalities from the local political, economic and scientific scene. “This ...

Proteros establishes Board of Directors and appoints industry experts

31-Mar-2010 - Proteros GmbH announced the formation of a Board of Directors which consists of leading experts with core competences in life sciences and corporate development. The Board will oversee all commercial and scientific activities and will support Proteros in its further corporate development and ...

ProteoNic and Genencor Sign Research Agreement

16-Jun-2009 - ProteoNic and Genencor, a Danisco Division, have signed a research agreement. As part of the contract, the two biotech companies will use ProteoNic’s UNic™ Toolbox to investigate enzyme production for Genencor’s fungal expression platforms. ProteoNic will support Genencor in applying the unique ...

Pall Opens New Centre of Excellence in India to Serve Fast-Growing Life Sciences Market

21-May-2007 - As part of its global initiative to align with customers worldwide, Pall Corporation inaugurated its newest Life Sciences Centre of Excellence in Bangalore, India. The Centre shall drive process optimization innovations for the global life sciences market to meet the evolving opportunities and ...

Invetech Extends its Specialized Services to the Biotechnology Market

15-May-2007 - Invetech has expanded its service offering to include novel early stage analysis and assessment services for biotechnology and biomedical clients. Building on its success in international instrument development and custom automation, Invetech announced the availability of this critical service to ...

Lonza Awarded Commercial Manufacturing Agreement with Altus Pharmaceuticals

21-Nov-2006 - Lonza Group Ltd announced that an agreement with Altus Pharmaceuticals Inc. has been signed, whereby Lonza is granted long term manufacturing rights for Altus' ALTU-135 drug substances. All related production will be conducted in Lonza's FDA registered facility in Kouím, Czech Republic. The scope ...

MediChem Life Sciences and Pharmacia Corporation Enter into Medicinal Chemistry Collaboration

09-Oct-2001 - Chicago, October 8, 2001 - MediChem Life Sciences, a drug discovery company, announced today that it has entered into a two-year strategic medicinal chemistry agreement with Pharmacia Corporation, a top-tier global pharmaceutical company. Under the terms of the agreement, MediChem will commit ...